Torna ai risultati
Scheda bibliografica · Consultazione e accesso
Artículo

Delineating novel diagnostic biomarkers and therapeutic targets for oral submucosal fibrosis: an integrative multi-omics and machine learning approach

Chinmay Nitin Mokal et al · Frontiers Media S.A · 2026

Testo completo ad accesso aperto
Lettura rapida. Controlla i dati essenziali della risorsa e accedi al contenuto con il pulsante principale. La scheda mostra solo le informazioni necessarie per identificare, citare e aprire l’opera.

Accesso alla risorsa

Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.

DOAJ DOAJ Articles
Entrar por DOAJ
Accesso principale

Testo completo ad accesso aperto

Texto completo identificado como acceso abierto.
Apri testo

Riepilogo

Descripción general del contenido del recurso.

BackgroundOral submucosal fibrosis (OSF) is a chronic and progressive disorder, caused by chewing areca nuts, affecting the oral cavity and oropharynx. OSF is characterized by severe symptoms like severe burning sensation, restricted mouth opening, etc. Given the multifactorial and poorly understood molecular basis of the disease, there is a need for novel biomarkers and therapeutic targets.MethodWe downloaded 3 RNA-seq, two microarray, one epigenomic, and one single-cell RNA-seq datasets from the gene expression omnibus database. Differentially expressed genes (DEGs) were characterized using DESeq2. Several analyses, including gene enrichment, immune cell infiltration, protein-protein interaction, and more, were performed. Machine learning models were developed using all DEGs and top5 selected features with leave one out cross validation technique. Independent validations were performed using two microarray datasets with appropriate statistical measures. Epigenetic analysis revealed hyper- and hypomethylated genes based on delta-beta values, and an integrative analysis of the transcriptome and methylome was performed to obtain key biomarkers. Single-cell analysis was performed to identify key cell types showing higher DEG expression.ResultDESeq2 analysis identified 29 upregulated and 15 downregulated DEGs. Upregulated DEGs show enrichment for the inflammatory, metabolic, and signaling processes, whereas downregulated DEGs were largely associated with metabolic processes. Immune cell enrichment analysis using CIBERSORTx shows higher enrichment of “T cells,” “mast cells,” and “macrophages” in OSF patients. We validated our findings in two independent microarray datasets and observed a similar gene expression pattern of DEGs. Machine learning performed using top5 features where Random Forest model achieved AUROC of 0.99 and AUPRC of 0.99. Further, ROC analysis and AUC plot show that DEGs can discriminate OSF patients from the normal population with high AUROC. Integrative analysis of methylation and transcriptomic data identified 11 genes as potential diagnostic biomarkers and therapeutic targets. Finally, single-cell analysis elucidates the higher expression of DEGs in “keratinocyte”, “epithelial cells” and “dendritic cells”.ConclusionIntegrative analysis identified 11 gene signatures as potential early diagnostic biomarkers and therapeutic targets for the OSF. Furthermore, the study hints towards mechanistic insight into potential mechanism leading to oral cancer. All the codes and ML models are provided at our GitHub repository https://github.com/agrawalpiyush-srm/OSF.

Come citare

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, C. N. M. E. (2026). Delineating novel diagnostic biomarkers and therapeutic targets for oral submucosal fibrosis: an integrative multi-omics and machine learning approach. https://doi.org/10.3389/fbinf.2026.1803111

MLA

al, Chinmay Nitin Mokal et. "Delineating novel diagnostic biomarkers and therapeutic targets for oral submucosal fibrosis: an integrative multi-omics and machine learning approach." 2026. https://doi.org/10.3389/fbinf.2026.1803111.

Chicago

al, Chinmay Nitin Mokal et. 2026. "Delineating novel diagnostic biomarkers and therapeutic targets for oral submucosal fibrosis: an integrative multi-omics and machine learning approach.". https://doi.org/10.3389/fbinf.2026.1803111.

Harvard

al, C. N. M. E. 2026, Delineating novel diagnostic biomarkers and therapeutic targets for oral submucosal fibrosis: an integrative multi-omics and machine learning approach, Frontiers Media S.A, available at: https://doi.org/10.3389/fbinf.2026.1803111 [Accessed 8 Aug. 2026].

Condividi e stampa

Salva la scheda, copia il link permanente o stampala in PDF.

Esporta riferimento

Esporta il record nei formati più comuni per usarlo con un gestore bibliografico.

Dettagli della risorsa

Informazioni bibliografiche utili per verificare che sia il materiale corretto.

Titolo
Delineating novel diagnostic biomarkers and therapeutic targets for oral submucosal fibrosis: an integrative multi-omics and machine learning approach
Autore / collaboratori
Chinmay Nitin Mokal et al
Editore
Frontiers Media S.A
Anno di pubblicazione
2026
ISSN
2673-7647
ISSN
2673-7647
Lingua
Inglés

Soggetti

Esplora risorse correlate a partire da questi soggetti.

Copiato